Regenix Super Speciality Laboratories Private Limited, a active private limited company, was established on 24 May 2011 in Chennai, Tamil Nadu, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U85300TN2011PTC080777. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.20 Cr and a paid-up capital of ₹1.19 Cr.
It upholds a compliant status. Employing 70 professional, Its leadership includes Malathi Ramamurthy (Managing Director), Samini (Whole-Time Director), Ramamurthy Ayyavuthevar (Director). Past directors included Malathi Ramamurthy, Ramamurthy Ayyavuthevar, Samugounder Subramaniam. It holds ₹1.11 M open charges and no settled loans. Its latest AGM occurred on 21 September 2024, with the balance sheet filed on 31 March 2024. It is based at Jamal Sonu Terrace, 42/1 Loganathan Nagar First Street, 100 Feet Road, Choolaimedu, Chennai, Tamil Nadu, 600094.
U85300TN2011PTC080777
080777
24 May 2011
₹1.20 Cr
₹1.19 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Regenix Super Speciality Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Malathi Ramamurthy | Managing Director | 15 Apr 2012 | Current |
| Samini | Whole-Time Director | 01 Oct 2022 | Current |
| Ramamurthy Ayyavuthevar | Director | 24 May 2011 | Current |
| Samugounder Subramaniam | Whole-Time Director | 24 May 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 May 2019 | Past |
| Pramod Abcsdd | Managing Director | 01 May 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 May 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Regenix Super Speciality Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.33% increase. The company also saw a substantial fall in profitability, with a 235.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Regenix Super Speciality Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,106,569.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2023 | Hdfc Bank Limited | ₹1.11 M | Open |
Explore comprehensive loan charge details -
Regenix Super Speciality Laboratories has a workforce of 70 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Regenix Super Speciality Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regenix Super Speciality Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Regenix Super Speciality Laboratories Private Limited last Annual general meeting of members was held on 21 Sep 2024 as per latest MCA records. was completed.
Progress on Regenix Super Speciality Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.11 Cr with Charge ID 100853453 was registered on 07 Nov 2023. was recorded as a recent event.
Samini was appointed as a Whole-time director was appointed as a Whole-time director on 01 Oct 2022 & has been associated with this company since 3 years 1 month . was recorded as a recent event.
The activity Malathi Ramamurthy was appointed as a Managing Director was appointed as a Managing Director on 15 Apr 2012 & has been associated with this company since 13 years 7 months . was completed.
The activity Ramamurthy Ayyavuthevar was appointed as a Director was appointed as a Director on 24 May 2011 & has been associated with this company since 14 years 6 months . was completed.
The CIN of Regenix Super Speciality Laboratories Private Limited is U85300TN2011PTC080777.
Regenix Super Speciality Laboratories Private Limited is headquartered at Jamal Sonu Terrace, 42/1 Loganathan Nagar First Street, 100 Feet Road, Choolaimedu, Chennai, Tamil Nadu, 600094.
Regenix Super Speciality Laboratories Private Limited was incorporated on 24 May 2011.
The current directors of Regenix Super Speciality Laboratories Private Limited are
The primary industry of Regenix Super Speciality Laboratories Private Limited is Hospital And Medical Care.
Regenix Super Speciality Laboratories Private Limited is unlisted.
The authorized capital of Regenix Super Speciality Laboratories Private Limited is ₹1.20 Cr, and the paid-up capital is ₹1.19 Cr.
The compliance status of Regenix Super Speciality Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX